803P Patient-reported outcomes in patients with resected, stage III BRAF V600+ melanoma treated with adjuvant dabrafenib + trametinib: COMBI-APlus study
- Resource Type
- Abstract
- Source
- In
Annals of Oncology September 2022 33 Supplement 7:S911-S912 - Subject
- Language
- ISSN
- 0923-7534